Clinical Trials Directory

Trials / Completed

CompletedNCT05672030

Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

Role of Interleukin 5 (IL-5) and IL-5R Signaling in Non-eosinophil Upper Airway Cells in Chronic Rhinosinusitis With Nasal Polyps

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The overarching hypothesis of this proposal is that IL-5 acts on multiple sinus tissue cell types, including plasma cells and epithelial cells, to promote immune dysregulation, and that inhibition of IL-5 affects several relevant effector pathways that lead to clinical benefit.

Detailed description

Further characterization of the role of IL-5Rα expression and function on human plasma cells will determine whether inhibiting IL-5 signaling on these cells offers therapeutic promise in other diseases related to plasma cell proliferation. Further characterization of human upper airway epithelial cell IL-5Rα expression and function will determine whether or not inhibiting IL-5 signaling on these cells offers therapeutic promise in other diseases related to epithelial dysfunction. IL-5Rα expression has been identified on several relevant sinus tissue effector cells, including on nasal polyp plasma cells and epithelial cells, and the aim of this study is to further the field by determining the consequences of IL-5 signaling on those cells.

Conditions

Interventions

TypeNameDescription
OTHERNon-InterventionalNo intervention.

Timeline

Start date
2022-10-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2023-01-05
Last updated
2025-11-24
Results posted
2025-11-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05672030. Inclusion in this directory is not an endorsement.